[SRNE] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
21-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- -183.19%
YoY- 49.07%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 13,034 6,929 20,407 4,019 1,337 798 101 124.71%
PBT -69,110 -55,746 -38,001 -12,724 -25,413 -10,207 -11,296 35.22%
Tax 309 -3,122 -90,424 -701 1,186 1 4 106.30%
NP -62,820 -49,776 12,425 -11,957 -23,476 -8,505 -11,296 33.08%
Tax Rate - - - - - - - -
Total Cost 75,854 56,705 7,982 15,976 24,813 9,303 11,397 37.13%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -481.97 -718.37 60.89 -297.51 -1,755.87 -1,065.79 -11,217.68 -40.80%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -0.34 -0.41 0.15 -0.23 -0.62 -0.23 -0.49 -5.90%
EPS Diluted -0.34 -0.41 0.15 -0.23 -0.62 -0.23 -0.49 -5.90%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.